Amgen and the Federal Trade Commission are settling the lawsuit the regulator filed to block the pharmaceutical giant’s $28 billion Horizon Therapeutics acquisition. As part of the settlement, Amgen agrees not to ‘bundle’ its products with Horizon’s drugs in negotiations with health plans.
The post Amgen, FTC Settlement Allows $28B Horizon Acquisition To Move Forward appeared first on Above the Law.
from Above the Law https://ift.tt/9PlXK37
via IFTTT